Optina Diagnostic

Optina has developed specialized hardware and proprietary A.I. software that enables a simple eye-scan to detect key biomarkers of cognitive diseases, first focused on Alzheimer’s disease. With pilots underway, their technology slashes pharma trial recruitment costs, dramatically improves patient diagnostics, catching cognitive decline much sooner for better management of cognitively-impaired populations.